Llwytho...
sST2 as a Novel Biomarker for the Prediction of In-hospital Mortality after Coronary Artery Bypass Grafting
OBJECTIVES: Soluble suppression of tumorgenicity 2 (sST2) biomarker is an emerging predictor of adverse clinical outcomes, but its prognostic value for in-hospital mortality after coronary artery bypass grafting (CABG) is not well understood. This study measured the association between operative sST...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Biomarkers |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534420/ https://ncbi.nlm.nih.gov/pubmed/30512977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2018.1556338 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|